Loss of body weight is dose-dependently associated with reductions in symptoms of hip osteoarthritis
Authors' conclusion
Our findings suggest that weight loss is associated with reduced symptoms of hip OA, supporting weight loss as an effective treatment strategy for hip OA.
Study context
- Population
- Adults with hip osteoarthritis (OA) in the Osteoarthritis Healthy Weight for Life (OAHWFL) program; mean age 65.14 years, 70% female, 78% with obesity (BMI ≥30 kg/m²)1,408 completed 18 weeks
- Participants
- 1,714 adults
- Exposure
- Categories of percentage weight change at 18 weeks
- Outcome
- Changes in the five HOOS subscales (Pain, Activity Limitations in Daily Living, Stiffness and Range of Motion, Sports and Recreation Function, Hip-related Quality of Life)
- Follow-up
- Baseline to 18 weeks
Methodological detailsretrospective audit of routinely collected healthcare data
- Retrospective audit of routinely collected healthcare data
Main finding
As reported in the abstract
Changes in all HOOS subscales vs percentage weight loss · 18 weeks
Greatest improvement: Hip-related Quality of Life subscale with >10% weight loss
14.42 points, 31.14%
Observational data: associations, not effects.
Original publication
Loss of body weight is dose-dependently associated with reductions in symptoms of hip osteoarthritis. Int J Obes (Lond). Published 17 October 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →